Article History
Received: 10 January 2023
Accepted: 20 February 2023
First Online: 21 March 2023
Declarations
:
: DM: chief investigator of the UK-ROX trial (Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care). NIHR130508. ADJ: received honoraria from Medtronic, Drager and Fisher-Paykel. PR: supported by the Deutsche Forschungsgemeinschaft (CRC 1149; project number 251293561).